
All-hands meeting, three weeks before the IPO. CEO: We are going to cure cancer, Alzheimer’s, heart disease and mental illness. In under a decade. Room: applause CEO: Step one. SWE-bench. Room: nodding CEO: Step two. The coding agent runs for 30 hours without stopping. VP: Incredible for patients. CEO: Step three. Terminal-Bench. Intern: Sorry, quick question. Why don’t we talk to the people who have worked on these diseases for decades and ask them what they need? CEO: Who are you? Intern: The intern. I just think the bottleneck might be trials, or wet lab time, or patient data. Probably not how fast we merge pull requests. CEO: Step four. The agent opens its own pull requests. Room: applause Intern: One oncologist could tell us in an hour if any of this is on the path. CEO: Why are you still here? Intern: Most Alzheimer’s drugs failed after they hit the target. They just didn’t help patients. A faster agent doesn’t fix that. CEO: Can someone find out who this is? Room: applause CEO: Step five. A better coding agent.
Dario Amodei says cancer, Alzheimer’s, heart disease, and mental illness will be relics of the past in less than a decade, and that "we can create an age of miracles" “You know, if today we look at things like cancer, Alzheimer’s, heart disease, mental illness, these will be relics of the past in, I think, less than a decade." "And I believe that the company which gets the risks right will also be the company that has the license to operate that society trusts and society believes can build the benefits in the right way." "I think if we do this right, we can create an age of miracles where humanity is able to solve problems that have eluded us for millennia." "We have to make sure that all the risks, all the ways that things can go wrong with this technology, we very carefully address those risks as we bring the benefits, and as we have a viable business at the same time.”
















